Finoriq research workspace
GE HealthCare Technologies Inc. (GEHC) SEC Filings & Filing Highlights
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of. Review GEHC SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
- Company
- GE HealthCare Technologies Inc. (GEHC)
- Ticker
- GEHC
- Market Cap
- $28.7B
- Latest Price
- $63.04
- Industry
- Medical Electronics
GE HealthCare Technologies Inc. (GEHC) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for GE HealthCare Technologies Inc. (GEHC).
| Event | Form | Date |
|---|---|---|
| GE HealthCare Technologies IncEffective as of May 7, 2026, the Company’s Board of Directors (the "Board") appointed Rodney F. Hochman as the Board's independent lead dir... | 8-K8.01 | 2026-05-11 |
| Broker Non-VotesGE HealthCare Technologies Inc. (the "Company," “we,” or “our") held its annual meeting of stockholders on May 7, 2026. Set forth below are... | 8-K5.07 | 2026-05-11 |
| GE HealthCare Technologies Inc.: Earnings or resultsOn April 29, 2026, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its first quarter 2026 financial res... | 8-K2.02 | 2026-04-29 |
| On March 17, 2026, the Company issued a press release announcing the appointment of Kevin A. Lo...On March 17, 2026, the Company issued a press release announcing the appointment of Kevin A. Lobo to its Board. A copy of the press release... | 8-K7.01 | 2026-03-17 |
| On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the...On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve... | 8-K5.02 | 2026-03-17 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.